Testing the efficacy of each individual drug alone and on potentiation of TRAIL response in GBM cells, the screen revealed the fungal metabolite chaetocin, previously identified as unselective histone methyltransferase inhibitor29 as a potential TRAIL-sensitizing agent. Here, TNFSF10 is linked to glioblastoma.